Teicoplanin inhibits Ebola pseudovirus infection in cell culture

There is currently no approved antiviral therapy for treatment of Ebola virus disease. To discover readily available approved drugs that can be rapidly repurposed for treatment of Ebola virus infections, we screened 1280 FDA-approved drugs and identified glycopeptide antibiotic teicoplanin inhibitin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yizhuo, Cui, Rui, Li, Guiming, Gao, Qianqian, Yuan, Shilin, Altmeyer, Ralf, Zou, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113690/
https://www.ncbi.nlm.nih.gov/pubmed/26585243
http://dx.doi.org/10.1016/j.antiviral.2015.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113690/
https://www.ncbi.nlm.nih.gov/pubmed/26585243
http://dx.doi.org/10.1016/j.antiviral.2015.11.003

Ejemplares similares